The Controversy Over the Use of Compounds Ivermectin/Fembendazole/Mebendazole What’s Real and What’s Not

Paul Thompson, M.D.

President, Thompson Clinic, Fort Worth, TX; Member, AMMG Planning Committee

Discussion of the controversy surrounding ivermectin, fenbendazole/mebendazole, and their use as repurposed complementary cancer treatments. The lecture reviews public and institutional skepticism, integrative medicine perspectives, and current and past research involving mechanisms such as resistant cancer cell targeting, glucose uptake inhibition, microtubule destabilization, apoptosis, P-gp inhibition, and combination studies involving checkpoint inhibitors.

Duration: 57m15s